Antheia recently joined some of the industry’s most notable thought leaders at the prestigious Forbes Sustainability Leaders Summit, which gathered on September 20 in New York City to discuss insights, innovations, and visions for a more sustainable future.
Antheia CEO and co-founder Dr. Christina Smolke had the honor of participating in a panel discussion that focused on achieving net-zero emissions in supply chains. During that panel, Dr. Smolke stressed the importance of rethinking the way we source Active Pharmaceutical Ingredients (API) and Key Starting Materials (KSM) for essential medicines.
Traditionally, these materials are sourced through agriculture means, which often is not the greenest option for production as it is the more resource-intensive and energy-demanding process. Dr. Smolke highlighted how Antheia’s groundbreaking technology offers a more sustainable solution by using bioengineered yeast to develop APIs/KSMs in bioreactors. This approach is not only more cost-effective in the long run, but it also enhances visibility and quality control, while reducing supply chain risks – all of which contribute to greener possibilities within pharmaceutical materials production.
See a clip of her panel discussion by clicking here.